These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15039681)

  • 41. "What Is Our Story?" Philip Morris's Changing Corporate Narrative.
    McDaniel PA; Malone RE
    Am J Public Health; 2015 Oct; 105(10):e68-75. PubMed ID: 26270280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How the tobacco industry targets children.
    Wolfe JA
    Am J Nurs; 2006 Nov; 106(11):13. PubMed ID: 17068419
    [No Abstract]   [Full Text] [Related]  

  • 43. Sometimes a cigar [magazine] is more than just a cigar [magazine]: pro-smoking arguments in Cigar Aficionado, 1992-2000.
    DeSantis AD; Morgan SE
    Health Commun; 2003; 15(4):457-80. PubMed ID: 14557079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The perimetric boycott: a tool for tobacco control advocacy.
    Offen N; Smith EA; Malone RE
    Tob Control; 2005 Aug; 14(4):272-7. PubMed ID: 16046691
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Flavored tobacco to E-cigarette's: How the tobacco industry sustains its product flow.
    Raj AT; Patil S; Gupta AA; Suveetha G
    Oral Oncol; 2018 Oct; 85():110. PubMed ID: 30087003
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of the 2003 advertising/promotion ban in the United Kingdom on awareness of tobacco marketing: findings from the International Tobacco Control (ITC) Four Country Survey.
    Harris F; MacKintosh AM; Anderson S; Hastings G; Borland R; Fong GT; Hammond D; Cummings KM;
    Tob Control; 2006 Jun; 15 Suppl 3(Suppl 3):iii26-33. PubMed ID: 16754943
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A grim contradiction: the practice and consequences of corporate social responsibility by British American Tobacco in Malaysia.
    Barraclough S; Morrow M
    Soc Sci Med; 2008 Apr; 66(8):1784-96. PubMed ID: 18304713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tobacco industry misappropriation of American Indian culture and traditional tobacco.
    D'Silva J; O'Gara E; Villaluz NT
    Tob Control; 2018 Jul; 27(e1):e57-e64. PubMed ID: 29459389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco industry marketing, population-based tobacco control, and smoking behavior.
    Pierce JP
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S327-34. PubMed ID: 18021907
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cigarette manufacturers' efforts to promote tobacco to the U.S. military.
    Joseph AM; Muggli M; Pearson KC; Lando H
    Mil Med; 2005 Oct; 170(10):874-80. PubMed ID: 16435763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Not Available].
    Humbel F; Sattler A; Schuurmans MM
    Praxis (Bern 1994); 2018; 107(6):315-322. PubMed ID: 29536814
    [No Abstract]   [Full Text] [Related]  

  • 52. Targeting Children and Their Mothers, Building Allies and Marginalising Opposition: An Analysis of Two Coca-Cola Public Relations Requests for Proposals.
    Wood B; Ruskin G; Sacks G
    Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31861344
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tobacco industry involvement in children's sugary drinks market.
    Nguyen KH; Glantz SA; Palmer CN; Schmidt LA
    BMJ; 2019 Mar; 364():l736. PubMed ID: 30872273
    [No Abstract]   [Full Text] [Related]  

  • 54. Tobacco industry direct marketing after the Master Settlement Agreement.
    Lewis MJ; Yulis SG; Delnevo C; Hrywna M
    Health Promot Pract; 2004 Jul; 5(3 Suppl):75S-83S. PubMed ID: 15231100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conflict of interest and FCTC implementation in China.
    Wan X; Ma S; Hoek J; Yang J; Wu L; Zhou J; Yang G
    Tob Control; 2012 Jul; 21(4):412-5. PubMed ID: 21676952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How Philip Morris unlocked the Japanese cigarette market: lessons for global tobacco control.
    Lambert A; Sargent JD; Glantz SA; Ling PM
    Tob Control; 2004 Dec; 13(4):379-87. PubMed ID: 15564622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Making big tobacco give in: you lose, they win.
    Wander N; Malone RE
    Am J Public Health; 2006 Nov; 96(11):2048-54. PubMed ID: 17018823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Direct-to-Consumer Marketing of Cigar Products in the United States.
    Ganz O; Teplitskaya L; Cantrell J; Hair EC; Vallone D
    Nicotine Tob Res; 2016 May; 18(5):864-8. PubMed ID: 26377513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tobacco industry surveillance of public health groups: the case of STAT (Stop Teenage Addiction to Tobacco) and INFACT (Infant Formula Action Coalition).
    Malone RE
    Am J Public Health; 2002 Jun; 92(6):955-60. PubMed ID: 12036789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Going below the line: creating transportable brands for Australia's dark market.
    Carter SM
    Tob Control; 2003 Dec; 12 Suppl 3(Suppl 3):iii87-94. PubMed ID: 14645953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.